Health and Fitness Health and Fitness
Mon, October 24, 2011
[ Mon, Oct 24th 2011 ] - Market Wire
Cigna to Acquire HealthSpring
Sat, October 22, 2011
Fri, October 21, 2011
Thu, October 20, 2011
Wed, October 19, 2011
Tue, October 18, 2011
Mon, October 17, 2011
Sun, October 16, 2011
Sat, October 15, 2011
Fri, October 14, 2011
Thu, October 13, 2011
Wed, October 12, 2011
[ Wed, Oct 12th 2011 ] - Market Wire
Financial Statement 10/11
Tue, October 11, 2011
[ Tue, Oct 11th 2011 ] - Market Wire
Aetna??Michael Elliott???????
Mon, October 10, 2011
Sun, October 9, 2011
Sat, October 8, 2011

ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2011 Financial Results


//health-fitness.news-articles.net/content/2011/ .. ast-of-third-quarter-2011-financial-results.html
Published in Health and Fitness on Tuesday, October 18th 2011 at 4:36 GMT by Market Wire   Print publication without navigation


October 18, 2011 07:30 ET

ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2011 Financial Results

IRVINE, CA--(Marketwire - Oct 18, 2011) - ISTA Pharmaceuticals, Inc. (NASDAQ: [ ISTA ]), today announced it will release third quarter 2011 financial results after the market closes on November 1, 2011. In conjunction, the Company will host a conference call at 4:30 p.m. Eastern Time to review the Company's commercial operations and provide pipeline updates.

Date: Tuesday, November 1, 2011
Time: 4:30 p.m. Eastern Time

Conference call access:
Internet: [ www.istavision.com ]
Domestic dial-in: 866.825.1692
International dial-in: 617.213.8059
Passcode: 90996630

To access the 24-hour audio replay, U.S. and Canadian participants may dial 888.286.8010; international participants may dial 617.801.6888. The access code for the replay is 93234261. This conference call will be webcast live and archived on ISTA's website until December 2, 2011.

About ISTA Pharmaceuticals

ISTA Pharmaceuticals, Inc. is a fast growing and the third largest branded prescription eye care business in the United States with an expanding focus on allergy therapeutics. ISTA currently markets four products, including treatments for ocular inflammation and pain post-cataract surgery, glaucoma and ocular itching associated with allergic conjunctivitis. The company's development pipeline contains additional candidates in various stages of development to treat dry eye, ocular inflammation and pain, and nasal allergies. Headquartered in Irvine, California, ISTA generated revenues of $156.5 million in 2010. For additional information about ISTA, please visit the corporate website at [ www.istavision.com ].



Publication Contributing Sources